These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7527870)

  • 1. [Predicting factors for the response to interferon therapy against hepatitis C virus infection: HCV genotyping].
    Yoshioka K; Kakumu S
    Rinsho Byori; 1994 Oct; 42(10):1010-4. PubMed ID: 7527870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for efficacy of interferon therapy in chronic hepatitis type C.
    Ishibashi K; Kashiwagi T; Ito A; Tanaka Y; Nagata T; Tamaki J; Azuma M; Kishida Y; Yoshida A; Hikiji AY
    Hepatogastroenterology; 1995; 42(5):535-41. PubMed ID: 8751211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
    Martinot-Peignoux M; Marcellin P; Pouteau M; Castelnau C; Boyer N; Poliquin M; Degott C; Descombes I; Le Breton V; Milotova V
    Hepatology; 1995 Oct; 22(4 Pt 1):1050-6. PubMed ID: 7557850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
    Kurosaki M; Enomoto N; Murakami T; Sakuma I; Asahina Y; Yamamoto C; Ikeda T; Tozuka S; Izumi N; Marumo F; Sato C
    Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative evaluation of serum HCV RNA by Roche Monitor Assay. Versions 1.0 and 2.0; as a predictive marker of subsequent response to IFN therapy].
    Takenokuchi M; Yasuda C; Nakamachi Y; Mukai M; Yoon S; Kondoh S; Kumagai S
    Rinsho Byori; 2002 Apr; 50(4):392-7. PubMed ID: 12014019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.
    McGuinness PH; Bishop GA; Painter DM; Chan R; McCaughan GW
    Hepatology; 1996 Apr; 23(4):676-87. PubMed ID: 8666317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C.
    Hayashi J; Ohmiya M; Kishihara Y; Tani Y; Kinukawa N; Ikematsu H; Kashiwagi S
    Am J Gastroenterol; 1994 Dec; 89(12):2151-6. PubMed ID: 7977232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA.
    McHutchison JG; Nainan OV; Alter MJ; Sedghi-Vaziri A; Detmer J; Collins M; Kolberg J
    Hepatology; 1997 Nov; 26(5):1322-7. PubMed ID: 9362379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.
    Bjøro K; Frøland SS; Yun Z; Samdal HH; Haaland T
    N Engl J Med; 1994 Dec; 331(24):1607-11. PubMed ID: 7526215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver].
    Hige S
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.
    Lunel F; Cresta P; Vitour D; Payan C; Dumont B; Frangeul L; Reboul D; Brault C; Piette JC; Huraux JM
    Hepatology; 1999 Feb; 29(2):528-35. PubMed ID: 9918931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C.
    Akahane Y; Miyazaki Y; Naitoh S; Takeda K; Tsuda F; Okamoto H; Itoh K; Miyakawa Y; Mayumi M
    Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.
    Karino Y; Toyota J; Sugawara M; Higashino K; Sato T; Ohmura T; Suga T; Okuuchi Y; Matsushima T
    Am J Gastroenterol; 1997 Jan; 92(1):61-5. PubMed ID: 8995939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA.
    Shiratori Y; Yokosuka O; Nakata R; Ihori M; Hirota K; Katamoto T; Unuma T; Okano K; Ikeda Y; Hirano M; Kawase T; Takano S; Matsumoto K; Ohashi Y; Omata M
    Hepatology; 1999 May; 29(5):1573-80. PubMed ID: 10216145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.